Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey

Background and Objectives: Immune-checitors have been established as a novel standard treatment for non-small cell lung cancer (NSCLC). The aim of this study was to identify factors associated with efficacy and nivolumab-related interstitial pneumonia in NSCLC by evaluating clinical data at the init...

Full description

Bibliographic Details
Main Authors: Hiroki Hata MS, Tadashi Mio PhD, Daisuke Yamashita BS, Chikako Matsumura PhD, Yugo Chisaki PhD, Hideyuki Motohashi PhD, Yoshitaka Yano PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820977200